Coya Therapeutics Inc
COYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$89.59M
Close$
$-0.44
108.2% downside
Current Fair Value
108.2% downsideOvervalued by 108.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $89.59 Million |
|---|---|
| Enterprise Value | $-49,392,420,940.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 0.62 |
| Outstanding Shares | 16,730,274 |
Return
| Return on Equity | -16.79% |
|---|---|
| Return on Assets | -15.44% |
| Return on Invested Capital | -17.18% |
Valuation & Multiples
| P/E Ratio | -4.28 |
|---|---|
| PEG | 313.33 |
| Price to Sales | 0.03 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -13.84 |
| Enterprise Value to EBIT | 5.78 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
$150,000
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$130,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 63,400▲ Infinity% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.61%▲ 1.16% |
|---|---|
| Total Invested | $32.05M▼ 30.40% |
| Investors Holding | 580% |
ESG Score
No data